CORONA Remedies Limited (NSE:CORONA)
India flag India · Delayed Price · Currency is INR
2,098.20
-14.80 (-0.70%)
At close: Jul 27, 2026

CORONA Remedies Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,8511,494905.03849.29-4
Depreciation & Amortization
376368.6279.84199.04202.82
Other Amortization
2.732.941.992.02
Loss (Gain) From Sale of Assets
5.47.112.050.2-
Loss (Gain) From Sale of Investments
-0.7-0.2-2.56-2.46-1.01
Loss (Gain) on Equity Investments
-2.7-3.8-0.06-2.28-
Provision & Write-off of Bad Debts
2.30.5-1.322.210.65
Other Operating Activities
119.3206.1278.5128.16-20.02
Change in Accounts Receivable
-262.1-183.6-126.31-129.171,329
Change in Inventory
52.1-333.964.71-314.54-433.47
Change in Accounts Payable
37.1294.2201.1698.28125.56
Change in Other Net Operating Assets
114.252.6-46.41296.28-224.01
Operating Cash Flow
2,2951,9051,5681,027977.05
Operating Cash Flow Growth
20.47%21.52%52.64%5.11%23.42%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-1,741-916.6-2,863-947.58-340.07
Sale of Property, Plant & Equipment
5.46.45.719.5-
Investment in Securities
-896.227.5144.61375.88-404.07
Other Investing Activities
70.644.146.6559.7586.34
Investing Cash Flow
-2,562-838.6-2,666-502.45-657.8

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
1,162-288.112.64-
Long-Term Debt Issued
--1,800--
Total Debt Issued
1,162-2,0882.64-
Short-Term Debt Repaid
--204.4---26.85
Long-Term Debt Repaid
-387.8-533.7-788.59-336.64-151.67
Total Debt Repaid
-387.8-738.1-788.59-336.64-178.52
Net Debt Issued (Repaid)
773.8-738.11,300-334-178.52
Common Dividends Paid
-447.1-226.3-169.41-69.72-69.94
Other Financing Activities
-73.9-101.3-144.66-43.75-50.14
Financing Cash Flow
252.8-1,066985.45-447.47-298.6

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
--0.02-0.38-0.3
Net Cash Flow
-13.90.6-113.3876.720.35

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
553.5988.3-1,29679.42636.98
Free Cash Flow Growth
-43.99%---87.53%84.55%
Free Cash Flow Margin
3.94%8.26%-12.77%0.90%10.32%
Free Cash Flow Per Share
9.0516.16-21.191.3612.48
Levered Free Cash Flow
-41.991,163-1,796-24.62-221.01
Unlevered Free Cash Flow
-0.111,227-1,709-0.07-192.59

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
73.9101.3144.6643.7550.14
Cash Income Tax Paid
494.2432.8179.05258.2214.99
Change in Working Capital
-58.7-170.793.15-49.15796.59